Browsing Tag
Centerview Partners
7 posts
Could Neurocrine’s $2.9bn Soleno deal turn VYKAT XR into its next rare-disease blockbuster?
Neurocrine is buying Soleno for $2.9 billion to add VYKAT XR. Read what the deal means for NBIX growth, rare-disease strategy, and investor sentiment.
PepsiCo closes $1.95bn Poppi deal: Can the gut health soda scale globally?
PepsiCo’s $1.95B acquisition of poppi strengthens its wellness drinks strategy—see how this Gen Z soda brand could reshape functional beverages.
Capital One closes Discover deal: What it means for credit cards and banking customers
Capital One finalizes acquisition of Discover, combining credit and payments networks. Find out what this means for banking customers and the U.S. finance sector.
Vestar Capital Partners completes $795m sale of Simple Mills to Flowers Foods
Vestar Capital Partners, a private equity firm focused on middle-market investments, has finalized the sale of Simple Mills,…
Emerson’s $265 per share tender offer signals strategic move to acquire full control of AspenTech
Emerson has formally launched its tender offer to acquire all remaining shares of Aspen Technology, Inc. (AspenTech) that…
Thomson Reuters to divest FindLaw to Internet Brands in strategic reconfiguration
Thomson Reuters (TSX/NYSE: TRI), a prominent global content and technology enterprise, has announced the execution of a definitive…
Apogee Enterprises to acquire UW Solutions for $240m to expand specialty coatings offerings
Apogee Enterprises, Inc. announced its plan to acquire UW Interco, LLC, a U.S.-based manufacturer known as UW Solutions,…